Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Muggia

Showing results (161-170 of 317) with videos related to

Pageof 32
Sort By:
Annals of Internal Medicine|August 1, 1977
Hepatotoxicity of combination chemotherapy for acute myelocytic leukemiaJ S Penta, D D Von Hoff, F M Muggia
Gynecologic Oncology|March 27, 2001
Doxil-induced radiation recall: a cause for false-positive PET scan findingsG Hornreich, C Schloss, W J Hoskins, et al.
Journal of Chronic Diseases|January 1, 1981
Methodology for the assessment of new dichotomous diagnostic testsM Staquet, M Rozencweig, Y J Lee, et al.
Cancer Investigation|January 1, 1989
Phase I/II trial of thymostimulin in opportunistic infections of the acquired immune deficiency syndromeA Chachoua, M D Green, F Valentine, et al.
Cancer|August 1, 1978
The chemotherapy of Hodgkin's disease: past experiences and future directionsV T DeVita, B J Lewis, M Rozencweig, et al.
Cancer Chemotherapy and Pharmacology|June 10, 1998
Tomudex (ZD1694, NSC 639186) in platinum-pretreated recurrent epithelial ovarian cancer: a phase II study by the Gynecologic Oncology GroupF M Muggia, J A Blessing, H D Homesley, et al.
Anticancer Research|January 1, 1981
Cisplatin: impact of a new anticancer agent on current therapeutic strategiesM Rozencweig, R Abele, D D von Hoff, et al.
Cancer Treatment Reports|April 1, 1984
Activity of mitolactol in cancer of the uterine cervixV Lira-Puerto, F Morales-Canfield, J Wernz, et al.
Cancer Treatment Reports|July 1, 1987
Phase II study of oral idarubicin in patients with AIDS-associated Kaposi's sarcomaA Chachoua, M Green, L Laubenstein, et al.
Progress in Clinical and Biological Research|January 1, 1985
Chemotherapy for locally advanced lung cancer: rationale and issuesF M Muggia, R H Blum, J S Cooper, et al.
Pageof 32

Showing results (161-170 of 317) with videos related to

Sort By:
Pageof 32
Annals of Internal Medicine|August 1, 1977
Hepatotoxicity of combination chemotherapy for acute myelocytic leukemiaJ S Penta, D D Von Hoff, F M Muggia
Gynecologic Oncology|March 27, 2001
Doxil-induced radiation recall: a cause for false-positive PET scan findingsG Hornreich, C Schloss, W J Hoskins, et al.
Journal of Chronic Diseases|January 1, 1981
Methodology for the assessment of new dichotomous diagnostic testsM Staquet, M Rozencweig, Y J Lee, et al.
Cancer Investigation|January 1, 1989
Phase I/II trial of thymostimulin in opportunistic infections of the acquired immune deficiency syndromeA Chachoua, M D Green, F Valentine, et al.
Cancer|August 1, 1978
The chemotherapy of Hodgkin's disease: past experiences and future directionsV T DeVita, B J Lewis, M Rozencweig, et al.
Cancer Chemotherapy and Pharmacology|June 10, 1998
Tomudex (ZD1694, NSC 639186) in platinum-pretreated recurrent epithelial ovarian cancer: a phase II study by the Gynecologic Oncology GroupF M Muggia, J A Blessing, H D Homesley, et al.
Anticancer Research|January 1, 1981
Cisplatin: impact of a new anticancer agent on current therapeutic strategiesM Rozencweig, R Abele, D D von Hoff, et al.
Cancer Treatment Reports|April 1, 1984
Activity of mitolactol in cancer of the uterine cervixV Lira-Puerto, F Morales-Canfield, J Wernz, et al.
Cancer Treatment Reports|July 1, 1987
Phase II study of oral idarubicin in patients with AIDS-associated Kaposi's sarcomaA Chachoua, M Green, L Laubenstein, et al.
Progress in Clinical and Biological Research|January 1, 1985
Chemotherapy for locally advanced lung cancer: rationale and issuesF M Muggia, R H Blum, J S Cooper, et al.
Pageof 32